DCK Protein (Myc-DYKDDDDK Tag)

N° du produit ABIN2719390

Cette protéine Recombinant DCK est exprimée dans HEK-293 Cells.

Aperçu rapide pour DCK Protein (Myc-DYKDDDDK Tag) (ABIN2719390)

Antigène: DCK (Deoxycytidine Kinase (DCK))

Type de proteíne: Recombinant

Origine: Humain

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Détail du produit

Purification/Conjugué: Cette DCK protéine est marqué à la Myc-DYKDDDDK Tag.

Attributs du produit:

• Recombinant human Deoxycytidine kinase protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: DCK (Deoxycytidine Kinase (DCK))

Autre désignation: Deoxycytidine Kinase

Sujet: Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

Poids moléculaire: 30.3 kDa

NCBI Accession: NP_000779